P

Inventor

HUNG CHIEN-FU

US21 patents
⚠️ This page may combine multiple inventors who share the name “HUNG CHIEN-FU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV JOHNS HOPKINS

16 patents
US7557200B2Jul 7, 2009

Superior molecular vaccine based on self-replicating RNA, suicidal DNA or naked DNA vector, that links antigen with polypeptide that promotes antigen presentation

UNIV JOHNS HOPKINS55 citations97
US7342002B2Mar 11, 2008

Molecular vaccine linking an endoplasmic chaperone polypeptide to an antigen

UNIV JOHNS HOPKINS16 citations92
US6734173B1May 11, 2004

HSP DNA vaccines

UNIV JOHNS HOPKINS42 citations92
US7318928B2Jan 15, 2008

Molecular vaccine linking intercellular spreading protein to an antigen

UNIV JOHNS HOPKINS17 citations77
US10799579B2Oct 13, 2020

Methods for enhancing antigen-specific immune responses

UNIV JOHNS HOPKINS4 citations72
US10350282B2Jul 16, 2019

Mesothelin vaccines and model systems

UNIV JOHNS HOPKINS1 citations70
US11766478B2Sep 26, 2023

Methods for enhancing antigen-specific immune responses

UNIV JOHNS HOPKINS1 citations62
US8007781B2Aug 30, 2011

Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen

UNIV JOHNS HOPKINS4 citations62
US11285197B2Mar 29, 2022

Mesothelin vaccines and model systems

UNIV JOHNS HOPKINS0 citations59
US11987606B2May 21, 2024

Compositions and methods for enhancing an immune response

UNIV JOHNS HOPKINS0 citations57
US12357673B2Jul 15, 2025

Compositions comprising albumin-FMS-like tyrosine kinase 3 ligand fusion proteins and uses thereof

UNIV JOHNS HOPKINS0 citations56
US12364980B2Jul 22, 2025

Non-invasive cancer detection and analysis by single-molecule imaging

UNIV JOHNS HOPKINS0 citations55
US11246908B2Feb 15, 2022

Compositions comprising albumin-FMS-like tyrosine kinase 3 ligand fusion proteins and uses thereof

UNIV JOHNS HOPKINS0 citations54
US10183985B2Jan 22, 2019

Compositions and methods for rendering tumor cells susceptible to CD8+ T cell-mediated killing

UNIV JOHNS HOPKINS0 citations49
US9561275B2Feb 7, 2017

Compositions and methods for rendering tumor cells susceptible to CD8+ T cell-mediated killing

UNIV JOHNS HOPKINS0 citations49
US12434236B2Oct 7, 2025

Methods and materials for treating cancer

UNIV JOHNS HOPKINS0 citations46

WU TZYY-CHOOU

5 patents